# ABSORB II Randomized Controlled Trial

Study · id `cardio:ct-nct01425281` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01425281](<https://clinicaltrials.gov/study/NCT01425281>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01425281

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 501 participants.

## Technical summary

Registry record NCT01425281. Randomized; single masking; primary purpose treatment. Start 2011-11 (registry gives no type); primary completion 2016-07 (actual). Results posted on 2019-09-04.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 501 participants (enrolled count; ClinicalTrials.gov record NCT01425281, source copy `cardio:ctgov-nct01425281-2019-11-13`, retrieved 2026-10-26)
- Start date: 2011-11 (registry gives no type) (ClinicalTrials.gov record NCT01425281, source copy `cardio:ctgov-nct01425281-2019-11-13`, retrieved 2026-10-26)
- Primary completion: 2016-07 (actual) (ClinicalTrials.gov record NCT01425281, source copy `cardio:ctgov-nct01425281-2019-11-13`, retrieved 2026-10-26)
- Completion: 2018-05-23 (actual) (ClinicalTrials.gov record NCT01425281, source copy `cardio:ctgov-nct01425281-2019-11-13`, retrieved 2026-10-26)
- Results first posted: 2019-09-04 (ClinicalTrials.gov record NCT01425281, source copy `cardio:ctgov-nct01425281-2019-11-13`, retrieved 2026-10-26)
- Countries: Belgium (ClinicalTrials.gov record NCT01425281, source copy `cardio:ctgov-nct01425281-2019-11-13`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01425281-2019-11-13`, retrieved 2026-10-26)

## The registry's words

- Brief title: ABSORB II Randomized Controlled Trial
- Acronym: ABSORB II
- Condition: Coronary Artery Disease
- Intervention (Device): Abbott Vascular XIENCE Everolimus Eluting Coronary Stent System
- Intervention (Device): Abbott Vascular ABSORB Everolimus Eluting Bioresorbable Vascular Scaffold System
- Lead sponsor: Abbott Medical Devices
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry lists this organization as the lead sponsor: Abbott (`cardio:abbott`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial (`cardio:pubmed-27806897`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Arterial Remodeling After Bioresorbable Scaffolds and Metallic Stents (`cardio:pubmed-28662808`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: dd1b83bfb5e4af802a33f111020a3889891c46b89748f3de77c1de1ed44daeca
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
